Breaking News Headlines Today

News from Clinical Trials Arena

All of today’s top news stories from Clinical Trials Arena. Get the full analysis behind how media bias impacts breaking news.

In total, 370 have been published by Clinical Trials Arena which Ground News has aggregated in the past 3 months.

Clinical Trials Arena’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

If you want to know if Clinical Trials Arena is credible or reliable, look no further. We rank Clinical Trials Arena as Unknown factuality. Find out more about our methodology here.

Information about Clinical Trials Arena

Where is Clinical Trials Arena located?Clinical Trials Arena's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Breakthrough Drug Cuts Dangerous Post-Bariatric Surgery Events by 64%: Phase 2 Trial Results Revealed

First-in-class GLP-1 antagonist avexitide shows promising results for post-bariatric hypoglycemia. Phase 3 LUCIDITY trial ongoing. See full efficacy data.FDA See the Story

Fucosyltransferase 4-Derived Peptide Bioconjugates on Carbon Nanotubes Enhance Antitumor Immunity in an Ovarian Cancer Mouse Model

Background. The interplay between ovarian cancer cells and immune cells within the immunosuppressive tumor microenvironment presents a significant challenge in the development of effective immunotherapies. Therefore, no immunotherapy has yet been approved to treat this disease...See the Story

Breakthrough: Crinetics' Once-Daily Oral PALSONIFY Matches Injectable Treatments in 96-Week Acromegaly Study

New long-term data reveals PALSONIFY maintains stable IGF-1 control with 91% patient retention, potentially replacing monthly injections. See full efficacy results.See the Story

WHO’s bold move to make clinical trials fairer for all

A strategic framework has been devised with nine priority actions to enhance quality, accessibility, innovation and sustainability in trials.The post WHO’s bold move to make clinical trials fairer for all appeared first on Clinical Trials Arena.Innovation Read Article

Pfizer and Astellas’ Xtandi improves OS as combination therapy

Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with nmHSPC, but only as a combination therapy.The post Pfizer and Astellas’ Xtandi improves OS as combination therapy appeared first on Clinical Trials Arena.Read Article

XyloCor doses first subject in Phase IIb trial of gene therapy candidate XC001

XyloCor has dosed the first subject in the multi-centre, randomised Phase IIb EXACT-2 trial to assess the gene therapy candidate, XC001.The post XyloCor doses first subject in Phase IIb trial of gene therapy candidate XC001 appeared first on Clinical Trials Arena.Read Article

Adapting To Funding And Operational Hurdles In Today’s Clinical Trials Landscape - Data Intelligence

Aditya Kotta, head of business development at Novotech, was one of the experts that discussed the emerging market trends in the early stage biotech landscape at OCT UK & Ireland. Credit: Athanasios Psimadis / Arena International. Events. Against the backdrop of geopolitical tensions and economic measures such as tariffs, which are influencing supply chains across numerous industries, biotech companies are facing significant capital constraints, …London, England · London See the Story

Updated NeoVax Cancer Vaccine Shows Improved Immune Response in Melanoma Trial

100% Center coverage: 4 sources

Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated formula and delivery of the NeoVax personalized cancer vaccine called NeoVaxMI is safe, feasible, and improves the vaccine-specific immune response compared to previous trials of the platform.Cancer See the Story

News from Clinical Trials Arena

News from Clinical Trials Arena

Information about Clinical Trials Arena

Media Bias Ratings

Factuality

Ownership

Top Clinical Trials Arena News

Victoria MLA Grace Lore Provides Update as She Continues to Battle Cancer

Breakthrough Research Uncovers Multiple Autism Subtypes with Unique Traits

Takeda Stock Rises After Positive Phase 3 Results for Narcolepsy Drug

Blindspots

Breakthrough Research Uncovers Multiple Autism Subtypes with Unique Traits

Breakthrough Drug Cuts Dangerous Post-Bariatric Surgery Events by 64%: Phase 2 Trial Results Revealed

Fucosyltransferase 4-Derived Peptide Bioconjugates on Carbon Nanotubes Enhance Antitumor Immunity in an Ovarian Cancer Mouse Model

Breakthrough: Crinetics' Once-Daily Oral PALSONIFY Matches Injectable Treatments in 96-Week Acromegaly Study

WHO’s bold move to make clinical trials fairer for all

Pfizer and Astellas’ Xtandi improves OS as combination therapy

XyloCor doses first subject in Phase IIb trial of gene therapy candidate XC001

Adapting To Funding And Operational Hurdles In Today’s Clinical Trials Landscape - Data Intelligence

Updated NeoVax Cancer Vaccine Shows Improved Immune Response in Melanoma Trial

Similar News Topics

Topics Most Covered by Clinical Trials Arena

Sources Covering Similar Topics

Breaking News Topics Related to Clinical Trials Arena